Ridgetech, Inc.
RDGTHealthcareNASDAQPharmaceutical Retailers
Scan Results
Daily timeframeRidgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The $720K market capitalization puts RDGT squarely in micro-cap range for its industry. It operates in two segments, Offline Wholesale and Online Platform.
Market Cap
$720,023
Beta
-0.10
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-17.21
EPS (Fwd)
—
ROE
-3.5%
ROA
-1.8%
Cash
$17.9M
Total Debt
$22,669
Free CF
$3.3M
52W Change
-99.7%
Annual Financials
Cash vs Debt
Where RDGT stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, RDGT finished 94.33% below its 150-day moving average ($14.65) and 99.04% below its 200-day moving average ($86.48). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is RDGT overbought or oversold?
At the October 20, 2026 close, RDGT's RSI(14) was 52.4, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Ridgetech, Inc. holds $17.9M in cash against $23K in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company generates $3.3M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -3.5%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has been relatively flat, moving from $120.2M (2023) to $132.2M (2026).
RDGT's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. With cash comfortably exceeding debt, RDGT has financial flexibility that may help navigate uncertain periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing RDGT.